Vabiotech confirms production of first batch of Sputnik V vaccine in Vietnam

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Singapore Seeking Pharmaceutical Tariff Concessions from US

The deputy prime minister and trade minister of Singapore,...

Merck to Acquire Verona for $10B, COPD Drug in Focus

Merck has pulled off another acquisition that happens to...

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

The Vietnamese pharmaceutical company Vabiotech confirmed on Wednesday the production of the first test batch of the Russian Sputnik V coronavirus vaccine at its facilities. Prior to that, the Russian Direct Investment Fund (RDIF) announced the start of production of the Sputnik V vaccine in Vietnam .

As noted by the representative of Vabiotech, the packaging of the trial batch of the vaccine, consisting of 30,000 doses, began about three weeks ago.

“We have just sent part of the produced vaccine to Russia for quality control,” he said.

Earlier, the Vietnamese Foreign Ministry announced that the Health Ministry and the RDIF would sign a contract for the packaging of up to 5 million doses of Sputnik V vaccine per month in Vietnam. According to the ministry, they also considered an option to transfer the technology for the production of the Russian vaccine in the amount of up to 100 mln doses per year to the Vietnamese side.

Sputnik V received registration from the Vietnamese Health Ministry on March 23 this year.

To date, Sputnik V has been registered in 68 countries with a total population of over 3.7 billion people, which is nearly half of the global population. The data obtained by regulators of a number of countries during the vaccination of the population, including Argentina, Serbia, Bahrain, Hungary, Mexico, UAE, Philippines and others, demonstrates that Sputnik V is one of the safest and most effective vaccines against coronavirus.

Latest stories

Related stories

Singapore Seeking Pharmaceutical Tariff Concessions from US

The deputy prime minister and trade minister of Singapore,...

Merck to Acquire Verona for $10B, COPD Drug in Focus

Merck has pulled off another acquisition that happens to...

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back